Combining discovery and targeted proteomics reveals a prognostic signature in oral cancer

被引：126

作者：

Carnielli, Carolina Moretto ^{[1
]}

Soares Macedo, Carolina Carneiro ^{[1
,2
]}

De Rossi, Tatiane ^{[1
]}

Granato, Daniela Campos ^{[1
]}

Rivera, Cesar ^{[1
,2
]}

Domingues, Romenia Ramos ^{[1
]}

Pauletti, Bianca Alves ^{[1
]}

Yokoo, Sami ^{[1
]}

Heberle, Henry ^{[3
]}

Busso-Lopes, Ariane Fidelis ^{[1
]}

Cervigne, Nilva Karla ^{[2
,4
]}

Sawazaki-Calone, Iris ^{[5
]}

Meirelles, Gabriela Vaz ^{[1
]}

Marchi, Fabio Albuquerque ^{[6
,7
]}

Telles, Guilherme Pimentel ^{[8
]}

Minghim, Rosane ^{[3
]}

Prado Ribeiro, Ana Carolina ^{[9
,10
]}

Brandao, Thais Bianca ^{[9
]}

Castro, Gilberto de, Jr. ^{[11
]}

Alejandro Gonzalez-Arriagada, Wilfredo ^{[12
]}

Gomes, Alexandre ^{[13
]}

Penteado, Fabio ^{[13
]}

Santos-Silva, Alan Roger ^{[2
]}

Lopes, Marcio Ajudarte ^{[2
]}

Rodrigues, Priscila Campioni ^{[14
,15
]}

Sundquist, Elias ^{[14
,15
]}

Salo, Tuula ^{[14
,15
,16
]}

da Silva, Sabrina Daniela ^{[17
,18
,19
,20
]}

Alaoui-Jamali, Moulay A. ^{[18
,19
,20
]}

Graner, Edgard ^{[2
]}

Fox, Jay W. ^{[21
]}

Della Coletta, Ricardo ^{[2
]}

Paes Leme, Adriana Franco ^{[1
]}

机构：

[1] CNPEM, Lab Espectrometria Massas, LNBio, BR-13083970 Campinas, SP, Brazil

[2] Univ Estadual Campinas UNICAMP, Fac Odontol Piracicaba, Dept Diagnost Oral, BR-13414903 Piracicaba, SP, Brazil

[3] Univ Sao Paulo, Inst Ciencias Matemat & Comp, BR-13560970 Sao Carlos, SP, Brazil

[4] FMJ, Dept Morfol & Patol Basica, BR-13202550 Jundiai, SP, Brazil

[5] Univ Estadual Oeste Parana, Fac Odontol, Ctr Ciencias Biol & Saude, BR-85819110 Cascavel, PR, Brazil

[6] AC Camargo Canc Ctr, Ctr Int Pesquisa CIPE, BR-01508010 Sao Paulo, SP, Brazil

[7] Inst Nacl Ciencia & Tecnol Oncogenom INCiTO, BR-01508010 Sao Paulo, SP, Brazil

[8] Univ Estadual Campinas UNICAMP, Inst Comp, BR-13083852 Campinas, SP, Brazil

[9] FMUSP, ICESP, Serv Odontol Oncol, BR-01246000 Sao Paulo, SP, Brazil

[10] Univ Brasil, BR-15600000 Fernandopolis, SP, Brazil

[11] ICESP, Inst Canc Estado Sao Paulo Octavio Frias de Olive, Serv Oncol Clin, BR-01246000 Sao Paulo, Brazil

[12] Univ Valparaiso, Fac Odontol, Valparaiso 2340000, Chile

[13] Waters Corp, BR-13070091 Campinas, SP, Brazil

[14] Univ Oulu, Canc & Translat Med Res Unit, FI-90014 Oulu, Finland

[15] Oulu Univ Hosp, Med Res Ctr, FI-90014 Oulu, Finland

[16] Univ Helsinki, Dept Oral & Maxillofacial Dis, Clinicum, FI-00014 Helsinki, Finland

[17] McGill Univ, Jewish Gen Hosp, Dept Otolaryngol Head & Neck Surg, Montreal, PQ H4A 3J1, Canada

[18] McGill Univ, Lady Davis Inst Med Res, Fac Med, Montreal, PQ H3T 1E2, Canada

[19] McGill Univ, Segal Canc Ctr, SMBD Jewish Gen Hosp, Dept Med,Fac Med, Montreal, PQ H3T 1E2, Canada

[20] McGill Univ, Segal Canc Ctr, SMBD Jewish Gen Hosp, Dept Oncol,Fac Med, Montreal, PQ H3T 1E2, Canada

[21] Univ Virginia, Dept Microbiol Immunol & Canc Biol, Charlottesville, VA 22903 USA

来源：

NATURE COMMUNICATIONS | 2018年 / 9卷

基金：

巴西圣保罗研究基金会;

关键词：

EPITHELIAL-MESENCHYMAL TRANSITION; SQUAMOUS-CELL CARCINOMA; QUANTITATIVE PROTEOMICS; TUMOR MICROENVIRONMENT; INVASIVE FRONT; COLLAGEN-VI; OVEREXPRESSION; PROLIFERATION; PROGRESSION; METASTASIS;

D O I：

10.1038/s41467-018-05696-2

中图分类号：

O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];

学科分类号：

07 ; 0710 ; 09 ;

摘要：

Different regions of oral squamous cell carcinoma (OSCC) have particular histopathological and molecular characteristics limiting the standard tumor-node-metastasis prognosis classification. Therefore, defining biological signatures that allow assessing the prognostic outcomes for OSCC patients would be of great clinical significance. Using histopathology-guided discovery proteomics, we analyze neoplastic islands and stroma from the invasive tumor front (ITF) and inner tumor to identify differentially expressed proteins. Potential signature proteins are prioritized and further investigated by immunohistochemistry (IHC) and targeted proteomics. IHC indicates low expression of cystatin-B in neoplastic islands from the ITF as an independent marker for local recurrence. Targeted proteomics analysis of the prioritized proteins in saliva, combined with machine-learning methods, highlights a peptide-based signature as the most powerful predictor to distinguish patients with and without lymph node metastasis. In summary, we identify a robust signature, which may enhance prognostic decisions in OSCC and better guide treatment to reduce tumor recurrence or lymph node metastasis.

引用

页数：17

共 50 条

[1] Combining discovery and targeted proteomics reveals a prognostic signature in oral cancer
Carolina Moretto Carnielli
Carolina Carneiro Soares Macedo
Tatiane De Rossi
Daniela Campos Granato
César Rivera
Romênia Ramos Domingues
Bianca Alves Pauletti
Sami Yokoo
Henry Heberle
Ariane Fidelis Busso-Lopes
Nilva Karla Cervigne
Iris Sawazaki-Calone
Gabriela Vaz Meirelles
Fábio Albuquerque Marchi
Guilherme Pimentel Telles
Rosane Minghim
Ana Carolina Prado Ribeiro
Thaís Bianca Brandão
Gilberto de Castro
Wilfredo Alejandro González-Arriagada
Alexandre Gomes
Fabio Penteado
Alan Roger Santos-Silva
Márcio Ajudarte Lopes
Priscila Campioni Rodrigues
Elias Sundquist
Tuula Salo
Sabrina Daniela da Silva
Moulay A. Alaoui-Jamali
Edgard Graner
Jay W. Fox
Ricardo Della Coletta
Adriana Franco Paes Leme
[J]. Nature Communications, 9
[2] A targeted proteomics approach reveals a serum protein signature as diagnostic biomarker for resectable gastric cancer
Shen, Qiujin
Polom, Karol
Williams, Coralie
de Oliveira, Felipe Marques Souza
Guergova-Kuras, Mariana
Lisacek, Frederique
Karlsson, Niclas G.
Roviello, Franco
Kamali-Moghaddam, Masood
[J]. EBIOMEDICINE, 2019, 44 : 322 - 333
[3] Mass spectrometry-based clinical proteomics indicates prognostic signature in oral cancer
Busso-Lopes, A.
Carnielli, C.
Granato, D.
Sa, J.
Santos, E.
Normando, A. G.
Trino, L.
Paes Leme, A.
[J]. FEBS OPEN BIO, 2022, 12 : 30 - 30
[4] Proteomics based prognostic signature of head and neck cancer
Ralhan, Ranju
Tripathi, Satyendra C.
Matta, Ajay
DeSouza, Leroi V.
Kaur, Jatinder
Grigull, Joerg
Chauhan, S. S.
Shukla, Nootan K.
Siu, K. W. Michael
[J]. CANCER RESEARCH, 2011, 71
[5] Salivary Proteomics for Oral Cancer Biomarker Discovery
Hu, Shen
Arellano, Martha
Boontheung, Pinmanee
Wang, Jianghua
Zhou, Hui
Jiang, Jiang
Elashoff, David
Wei, Roger
Loo, Joseph A.
Wong, David T.
[J]. CLINICAL CANCER RESEARCH, 2008, 14 (19) : 6246 - 6252
[6] Development of cancer prognostic signature based on pan-cancer proteomics
Huang, Weiguo
Chen, Jianhui
Weng, Wanqing
Xiang, Yukai
Shi, Hongqi
Shan, Yunfeng
[J]. BIOENGINEERED, 2020, 11 (01) : 1368 - 1381
[7] Discovery and Validation of Clinical Biomarkers of Cancer: A Review Combining Metabolomics and Proteomics
Srivastava, Anubhav
Creek, Darren John
[J]. PROTEOMICS, 2019, 19 (10)
[8] Discovery proteomics reveals potential protein signature associated with malignant phenotype acquisition in pleomorphic adenoma
de Lima-Souza, Reydson Alcides
Scarini, Joao Figueira
Lavareze, Luccas
Emerick, Carolina
Crescencio, Livia Ramalho
Domingues, Romenia Ramos
Paes Leme, Adriana Franco
Linhares Almeida Mariz, Bruno Augusto
Bastos, Debora Campanella
Machado, Renato Assis
Tincani, Alfio Jose
Del Negro, Andre
Chone, Carlos Takahiro
Kowalski, Luiz Paulo
Abu Egal, Erika Said
Altemani, Albina
Mariano, Fernanda Viviane
[J]. ORAL DISEASES, 2023, 29 (03) : 1017 - 1027
[9] Targeted proteomics: Biomarker discovery and validation for the early detection of breast cancer
Li, J.
Zhou, J.
Chan, D. W.
[J]. CLINICAL CHEMISTRY, 2008, 54 (06) : A126 - A126
[10] Targeted proteomics on its way to discovery
Mendes, Marta L.
Dittmar, Gunnar
[J]. PROTEOMICS, 2022, 22 (15-16)

← 1 2 3 4 5 →